US 11351266
Conjugate of isotretinoin and peptide
granted A61KA61K2800/522A61K31/19
Quick answer
US patent 11351266 (Conjugate of isotretinoin and peptide) held by CAREGEN CO., LTD. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CAREGEN CO., LTD.
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2800/522, A61K31/19, A61K47/64, A61K8/64